Brief: Camurus Reports Positive Topline Results For CAM2056

Camurus AB

10/11/2025 07:10

Nov 10 (Reuters) - Camurus AB CAMX.ST:

REPORTS POSITIVE TOPLINE RESULTS FOR CAM2056, SEMAGLUTIDE MONTHLY DEPOT

CAM2056 SHOWED WEIGHT AND A1C REDUCTIONS COMPARABLE TO OR EXCEEDING THOSE SEEN FOR WEEKLY SEMAGLUTIDE (WEGOVY®)

RESULTS INCLUDE A 9.3% WEIGHT REDUCTION WITH CAM2056 VERSUS. 5.2% WITH WEEKLY SEMAGLUTIDE AT DAY 85

SAFETY AND TOLERABILITY WERE CONSISTENT WITH WEEKLY SEMAGLUTIDE

CAM2056 HAS POTENTIAL FOR MONTHLY DOSING WITH RAPID INITIATION

Source text: [source]

Further company coverage: CAMX.ST

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))